DIPRAMIDA® Oral Solution
Antiemetic – Gastrokinetic.
Indicated in the management of vomiting of diverse etiology, in reflux esophagitis and in gastric motility disorders. It is also indicated in the preparation of radiological studies of the digestive tract.
Technical Specification
Species
Dogs and cats.
Dosage form
Oral solution.
Therapeutic action
Antiemetic – Gastrokinetic.
Composition
Each 1 mL of oral solution contains:
Metoclopramide hydrochloride monohydrate .........5.27 mg
(Equivalent to 5 mg of Metoclopramide hydrochloride)
Excipients q.s.p ......................................................1 mL
Indications
Indicated in the management of vomiting of diverse etiology, in reflux esophagitis and in gastric motility disorders. It is also indicated in the preparation of radiological studies of the digestive tract.
Route od administration and dosage
Oral administration:
Active ingredient dose:
0.25 – 0.5 mg/Kg of weight, three times a day.
Product dose:
1 - 2 drops/Kg of weight, three times a day.
Administer 30-45 minutes before the meal and at the time of sleep.
Drug interactions
- Avoid concomitant administration with anticholinergics. Atropine may block the effect of Metoclopramide on gastrointestinal motility.
- Phenothiazine tranquilizers can potentiate the effects centrally.
Contraindications
- Do not administer in cases of gastrointestinal obstruction or perforation.
- Do not administer in patients with hypersensitivity to Metoclopramide.
- Do not administer to pregnant or lactating females.
Special precautions for the operator
- In the case of contact with the skin or eyes, it is recommended to wash with plenty of water. If irritation develops and persists, see a doctor.
- In case of ingestion, do not induce vomiting. Get medical help.
Warnings
Special warnings and precautions for use:
- Keep out of the reach of children.
- It is recommended to administer with caution in epileptic patients.
Adverse effects
In dogs, the most common adverse reactions, although rare, include changes in mental status and behavior (restlessness, involuntary spasms, aggression, hyperactivity or drowsiness, and depression). Cats may show signs of excitement or disorientation. Both species can develop constipation in prolonged treatments.
Observations
Shake before use.
Special precautions for the disposal of unused product or waste material:
Empty containers can be discarded as household waste, without any special precautions. Do not dispose of containers with product residues on the ground or water courses. For expired or unused products, contact the manufacturing laboratory.
Conservation
Store between 15 ° and 30 ° C, protected from light. Once the container is opened, use within 12 weeks. Discard the unused product after that period of time.
Condition of sale
Supply only on veterinary prescription.
Presentation
Bottle containing 20 mL
Prepared by
Drag Pharma Laboratory.
Records
Chile: Reg. SAG N°: 1818
Perú: Registro SENASA F.43.32.I.0020
Countries where it is marketed
Imported and Distributed in Peru by:
Representaciones Durand SAC.
Av. Manuel Olguín N° 501 Oficina N° 604
Santiago de Surco Lima.
Imported and distributed in Bolivia by:
ZOOFARMA
TEL: +(591)222-3357
Street Díaz Romero 1339, La Paz.
You have entered drug info or veterinary products intended exclusively (s) kind (s) indicated (s).
Drag Pharma Lab is not responsible for the consequences of misuse of the products, and the use of this information without consulting a veterinarian